Geode Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.64M | Buy |
1,279,496
+37,679
| +3% | +$284K | ﹤0.01% | 2392 |
|
|
2025
Q1 | $9.4M | Buy |
1,241,817
+27,176
| +2% | +$206K | ﹤0.01% | 2330 |
|
|
2024
Q4 | $14.8M | Buy |
1,214,641
+6,220
| +0.5% | +$75.8K | ﹤0.01% | 2125 |
|
|
2024
Q3 | $20.2M | Buy |
1,208,421
+231,935
| +24% | +$3.88M | ﹤0.01% | 1969 |
|
|
2024
Q2 | $17M | Buy |
976,486
+299,156
| +44% | +$5.22M | ﹤0.01% | 2025 |
|
|
2024
Q1 | $11.5M | Buy |
677,330
+21,666
| +3% | +$369K | ﹤0.01% | 2243 |
|
|
2023
Q4 | $6.68M | Buy |
655,664
+64,841
| +11% | +$661K | ﹤0.01% | 2555 |
|
|
2023
Q3 | $5.35M | Buy |
590,823
+78,477
| +15% | +$710K | ﹤0.01% | 2601 |
|
|
2023
Q2 | $5.51M | Sell |
512,346
-25,477
| -5% | -$274K | ﹤0.01% | 2627 |
|
|
2023
Q1 | $5.5M | Sell |
537,823
-19,285
| -3% | -$197K | ﹤0.01% | 2596 |
|
|
2022
Q4 | $5.88M | Buy |
557,108
+15,588
| +3% | +$164K | ﹤0.01% | 2582 |
|
|
2022
Q3 | $6.94M | Buy |
541,520
+36,526
| +7% | +$468K | ﹤0.01% | 2484 |
|
|
2022
Q2 | $6.47M | Buy |
504,994
+62,453
| +14% | +$801K | ﹤0.01% | 2553 |
|
|
2022
Q1 | $4.63M | Buy |
442,541
+10,670
| +2% | +$112K | ﹤0.01% | 2837 |
|
|
2021
Q4 | $6.66M | Buy |
431,871
+10,633
| +3% | +$164K | ﹤0.01% | 2722 |
|
|
2021
Q3 | $9.51M | Buy |
421,238
+188,316
| +81% | +$4.25M | ﹤0.01% | 2479 |
|
|
2021
Q2 | $6M | Buy |
232,922
+12,655
| +6% | +$326K | ﹤0.01% | 2794 |
|
|
2021
Q1 | $9.18M | Buy |
+220,267
| New | +$9.18M | ﹤0.01% | 2417 |
|